ANNOUNCEMENT of ACQUISITION notice comments
Profit: $1.1m ongoing?
Announcement says "...revenue of at least $3.5m and approx $1.1m NPAT in each of the past 3 years..."
However it ALSO says that the $9m cash multiple is "... 9.6x FY21 normalised NPAT". THAT calculation is $0.9375m NPAT
ALSO corroborated in the description of impact on LBL FY21 on pro forma
"normalised" FY21 QSP would have added to LBL FY21 NPAT $0.9m, EBITDA $1.6m, and revenue $3.8m
I'm not quite sure what that normalisation has included for QSP, but that $0.9m works out about 0.81c per share. 2021 NPAT was 2.95 cps.
MD/CEO staying on?
not sure if founding MD counts as "employee", but: "Laserbond expects all existing QSP employees will accept the offer of employment with Laserbond"
Question on whether CAPEX last few years has affected historical NPAT: Don't forget the instant asset write-off andNot an accountant, but instant asset write off and temporary full-expensing of assets would have affected this?
Corporate governance and disclosure...see next post
- Forums
- ASX - By Stock
- LBL
- Ann: LaserBond Expands to Queensland
LBL
laserbond limited
Add to My Watchlist
0.00%
!
36.0¢

Ann: LaserBond Expands to Queensland, page-12
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
36.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $42.35M |
Open | High | Low | Value | Volume |
36.0¢ | 36.5¢ | 36.0¢ | $219.3K | 608.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 49047 | 36.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.5¢ | 18685 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 49047 | 0.360 |
5 | 79787 | 0.355 |
2 | 10132 | 0.350 |
2 | 30030 | 0.345 |
6 | 21741 | 0.340 |
Price($) | Vol. | No. |
---|---|---|
0.365 | 14354 | 1 |
0.370 | 11746 | 2 |
0.380 | 75000 | 2 |
0.385 | 60000 | 2 |
0.390 | 43000 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
LBL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online